A Sensitive Assay for Measuring Alpha-Gal Epitope Expression on Cells by a Monoclonal Anti-Gal Antibody
Overview
Authors
Affiliations
Background: The assessment of a-gal epitope (Galalpha1-3Galbeta1-4GlcNAc-R) expression on various cells and tissues is important for the prediction of anti-Gal-mediated immune rejection of xenografts. This study describes an enzyme-linked immunosorbent assay (ELISA inhibition assay) developed for this purpose, which uses the monoclonal anti-Gal antibody M86.
Methods: Cells at various concentrations were incubated overnight with M86 at 1/100 dilution. The cells and bound antibody were removed, and the residual antibody in the supernatant was measured in an ELISA assay with a-gal-bovine serum albumin as a solid phase antigen. The extent of a-gal epitope expression on cells correlates with the subsequent inhibition of M86 binding in ELISA. The inhibition binding curves at various cell concentrations were compared with those of a standard cell line with a known number of epitopes per cell.
Results And Conclusions: The mouse IgM M86 monoclonal antibody was highly specific for a-gal epitopes. Using this antibody in an ELISA inhibition assay with cells at a wide range of concentrations enables the detection of at least 5 x 10(4) and up to more than 5 x 10(7) a-gal epitopes per cell. This assay can be used also for the detection of a-gal epitopes on membranes from tissue homogenates, and thus it enables the determination of the extent of decrease in a-gal epitope expression in animals that are genetically manipulated to alter their carbohydrate make-up.
Self-Tumor Antigens in Solid Tumors Turned into Vaccines by α-gal Micelle Immunotherapy.
Galili U Pharmaceutics. 2024; 16(10).
PMID: 39458595 PMC: 11510312. DOI: 10.3390/pharmaceutics16101263.
Deciphering Immunotoxicity in Animal-Derived Biomaterials: A Genomic and Bioinformatics Approach.
Lian H, Liu Y, Ke L, Han Q Int J Mol Sci. 2024; 25(20).
PMID: 39456747 PMC: 11507131. DOI: 10.3390/ijms252010963.
Alpha-Gal Bound Aptamer and Vancomycin Synergistically Reduce Infection In Vivo.
Doherty M, Shaw C, Woods L, Weimer B Microorganisms. 2023; 11(7).
PMID: 37512948 PMC: 10383818. DOI: 10.3390/microorganisms11071776.
Mu Y, Zhang Y, Wei L, Chen L, Hao F, Shao A Mater Today Bio. 2022; 18:100505.
PMID: 36471894 PMC: 9719100. DOI: 10.1016/j.mtbio.2022.100505.
Kreft L, Schepers A, Hils M, Swiontek K, Flatley A, Janowski R Front Immunol. 2022; 13:958952.
PMID: 35990627 PMC: 9391071. DOI: 10.3389/fimmu.2022.958952.